Status:
RECRUITING
Human Blood Cell Disorders Tissue Bank
Lead Sponsor:
Northwell Health
Conditions:
Human Blood Cell Disorders
Lymphoid, Myeloid and Erythroid Proliferative Disease
Eligibility:
All Genders
18-100 years
Brief Summary
The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, a...
Eligibility Criteria
Inclusion
- Participants or participant's Legally Authorized Representatives (LAR) must be able to understand and render voluntary, written informed consent.
- Patients must be able to contribute the required amount of blood and/or tissue without compromising their well-being or care.
- Participants must be willing to be contacted again for consideration of additional studies in the future, such as a blood draw or another action (e.g., bone marrow aspiration and/or biopsy) that would be done as part of their standard of care.
Exclusion
- Patients who are known to be anemic, with hemoglobin \<8.0g/dl.
- Patients who are known to be infected with HIV.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2035
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT00902447
Start Date
April 1 2009
End Date
January 1 2035
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Feinstein Institute for Medical Research
Manhasset, New York, United States, 11030